Now, the Medical Marijuana and Cannabidiol Research Expansion bill will (hopefully) make it easier for researchers to study the marijuana plant. It also contains literature urging the federal government to analyze the plant’s therapeutic benefits, which may possible help push the rescheduling review which is set for Biden to do in October. In addition, the bill will enable research universities and private firms to obtain licenses from the US Drug Enforcement Administration so that they can grow and study it for the purpose of research.
Legal on paper, restricted in practice. Inside Germany’s cannabis system, where cultivation is allowed but…
The idea may sound strange: a tobacco plant producing compounds like psilocybin or DMT. Sounds…
The term “addiction” gets thrown around quite freely in everyday language—this is nothing new. Who…
Three days before the Trump administration moved medical marijuana to Schedule III, a new YouGov…
On April 23, 2026, the Trump administration officially moved FDA-approved marijuana products and marijuana products…
Here we are in 2026, and a conflict that was supposed to wrap up in…